⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 24, 2026

Relpax 40 mg - Filmtabletten 40 mg (Filmtablette)

📷 Wikipedia: Eletriptan · Source
Relpax 40 mg - Filmtabletten 40 mg (Filmtablette)
📷 Wikipedia: Eletriptan · Source
Relpax 40 mg film-coated tablets are subject to a parallel export ban.
⚠️
Shortage ongoing
ELETRIPTAN HYDROBROMID is currently in short supply in AT.
📈 Timeline
18 days active so far
August 25, 2026 September 11, 2026

What is this? Relpax is a medicine used to treat migraine headaches. It comes in small tablets you swallow.

What's happening? Some packs of Relpax 40 mg are not available right now. The company expects more supplies on September 23.

Does this affect me? If you take Relpax 40 mg, you may have trouble finding it. Smaller packs are still in stock.

What should I do? Ask your pharmacist or doctor for advice before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ELETRIPTAN HYDROBROMID
Agency-published detail

🚫 Parallel export ban active · ATC: N02CC06 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Viatris Healthcare Limited, Damastown Road Damastown Industrial Park -, D15 XD71 Dublin 15, Irland · Affected packs: 6 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-18, resupply 2026-09-23] · 2 Stück Schachtel, Blisterpackung [verfügbar]

First published
August 24, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Relpax 40 mg - Filmtabletten 40 mg (Filmtablette). Relpax 40 mg film-coated tablets are subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on August 24, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.